Skip to content
value.today

Baxano Surgical, Inc.

Total raised
$11 M
2 rounds on record
Latest round
$10 M
Mar 2014
First round on record
Dec 2013
Today
Private
No later event on record

Funding rounds

2 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Baxano Surgical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2014$10 MNo. 2$2 to $10 million

Baxano Surgical, Inc.: Raise no. 2, Mar 2014

Investors in this round

5 investors had bought by the notice of Mar 26, 2014: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
$699,557
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frederic C. Feiler, Jr. · Executive Officer
  • Greg D. Slusser · Executive Officer
  • Greg M. Welsh · Executive Officer
  • Ken Reali · Executive Officer, Director
  • Matthew D. Pickens · Executive Officer
  • Mukesh M. Ramchandani · Executive Officer
  • Stephanie M. Fitts · Executive Officer
  • Stephen D. Ainsworth · Executive Officer
  • Timothy M. Shannon · Executive Officer
  • David Simpson · Director
  • James Shapiro · Director
  • Jeffrey Fischgrund · Director
  • Mark Stautberg · Director
  • Paul Laviolette · Director
  • Roderick A. Young · Director
  • Russell C. Hirsch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • STIFEL, NICOLAUS & COMPANY, INC. (CRD 793) · New York, New YorkSold in CA, NJ
  • PIPER JAFFRAY & CO. (CRD 665) · Minneapolis, MinnesotaSold in CA, NJ

Signed by Timothy M. Shannon, Chief Financial Officer. Newest notice filed Mar 26, 2014. Read the notice at the SEC.

debt, optionsSEC
Dec 2013$1 MNo. 1Under $2 million

Baxano Surgical, Inc.: Raise no. 1, Dec 2013

Investors in this round

1 investor had bought by the notice of Dec 17, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frederic C. Feiler, Jr. · Executive Officer
  • Greg D. Slusser · Executive Officer
  • Greg M. Welsh · Executive Officer
  • Ken Reali · Executive Officer, Director
  • Mukesh M. Ramchandani · Executive Officer
  • Stephanie M. Fitts · Executive Officer
  • Stephen D. Ainsworth · Executive Officer
  • Timothy M. Shannon · Executive Officer
  • David Simpson · Director
  • James Shapiro · Director
  • Jeffrey Fischgrund · Director
  • Mark Stautberg · Director
  • Paul Laviolette · Director
  • Roderick A. Young · Director
  • Russell C. Hirsch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “In connection with a loan, the Issuer issued to Hercules Technology Growth Capital, Inc. a warrant exercisable for up to 1,176,471 shares of the Issuer's common stock at an exercise price of $1.02 per share.”

Signed by Timothy M. Shannon, Interim Chief Financial Officer. Newest notice filed Dec 17, 2013. Read the notice at the SEC.

equity, optionsSEC
May 2013$37 MIssued in a merger or acquisition$10 to $50 million

Baxano Surgical, Inc.: Private sale, May 2013

Investors in this round

23 investors had bought by the notice of Jun 12, 2013: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $37 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frederic C. Feiler, Jr. · Executive Officer
  • Greg M. Welsh · Executive Officer
  • Joseph A. Slattery · Executive Officer
  • Ken Reali · Executive Officer, Director
  • Mukesh M. Ramchandani · Executive Officer
  • Stephanie M. Fitts · Executive Officer
  • Stephen D. Ainsworth · Executive Officer
  • David Simpson · Director
  • James Shapiro · Director
  • Jeffry Fischgrund · Director
  • Mark Stautberg · Director
  • Paul Laviolette · Director
  • Roderick A. Young · Director
  • Russell C. Hirsch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Y. Sartorio, Attorney-in-Fact. Newest notice filed Jun 12, 2013. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Baxano Surgical, Inc. had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Mar 2014).

    SEC Form D (revenue range) · Mar 2014

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2014

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Baxano Surgical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Baxano Surgical, Inc.
NameRoleNamed in
Frederic C. Feiler, Jr.Executive officerMar 2014
Greg D. SlusserExecutive officerMar 2014
Greg M. WelshExecutive officerMar 2014
Ken RealiExecutive officerMar 2014
Matthew D. PickensExecutive officerMar 2014
Mukesh M. RamchandaniExecutive officerMar 2014
Stephanie M. FittsExecutive officerMar 2014
Stephen D. AinsworthExecutive officerMar 2014
Timothy M. ShannonExecutive officerMar 2014
Joseph A. SlatteryExecutive officerJun 2013
David SimpsonDirectorMar 2014
James ShapiroDirectorMar 2014
Jeffrey FischgrundDirectorMar 2014
Ken RealiDirectorMar 2014
Mark StautbergDirectorMar 2014
Paul LavioletteDirectorMar 2014
Roderick A. YoungDirectorMar 2014
Russell C. HirschDirectorMar 2014
Jeffry FischgrundDirectorJun 2013